Algorae Pharmaceuticals (ASX:1AI) Common Stock: A$81.73 Mil (As of Dec. 2025)


What is Algorae Pharmaceuticals Common Stock?

Algorae Pharmaceuticals ASX:1AI Common Stock is A$81.73 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Algorae Pharmaceuticals's quarterly common stock stayed the same from Dec. 2024 (A$81.54 Mil) to Jun. 2025 (A$81.54 Mil) but then increased from Jun. 2025 (A$81.54 Mil) to Dec. 2025 (A$81.73 Mil).

Algorae Pharmaceuticals's annual common stock increased from Jun. 2023 (A$80.24 Mil) to Jun. 2024 (A$81.54 Mil) but then stayed the same from Jun. 2024 (A$81.54 Mil) to Jun. 2025 (A$81.54 Mil).

Algorae Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Algorae Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Algorae Pharmaceuticals Common Stock Chart

Algorae Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.37 78.95 80.24 81.54 81.54

Algorae Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.53 81.54 81.54 81.54 81.73

Algorae Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$81.73 Mil mean?
Algorae Pharmaceuticals (ASX:1AI) has a Common Stock of A$81.73 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Algorae Pharmaceuticals and its competitors.
Is Algorae Pharmaceuticals' Common Stock too high?
Algorae Pharmaceuticals' current Common Stock is A$81.73 Mil.
How does Algorae Pharmaceuticals' Common Stock compare to VRTX and REGN?
Algorae Pharmaceuticals' Common Stock of A$81.73 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Algorae Pharmaceuticals and its competitors. Algorae Pharmaceuticals's current Common Stock is A$81.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Algorae Pharmaceuticals stock overvalued right now?
Algorae Pharmaceuticals (ASX:1AI) has a current Common Stock of A$81.73 Mil. The current Common Stock is A$81.73 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Algorae Pharmaceuticals (ASX:1AI), the current Common Stock is A$81.73 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Algorae Pharmaceuticals Business Description

Other Exchanges LVCLF:USALHI0:Germany
Address 525 Collins Street, Level 23, Rialto South Tower, Melbourne, VIC, AUS, 3000
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.